While directly targeting ABC transporters has yielded disappointing results, studying the signalling pathways that contribute to ABC transporter function will be of great relevance for the design of future therapeutic strategies, to overcome resistance and eradicate cancer. This evidence concerns the gene ABCG2 and cancer.